Operations
AI-powered dental practice technology company Peerlogic and AI-enabled clinical trial design company QuantHealth also scored investments.
Clinical consultant at Beckman Coulter Diagnostics Sophia Henry discusses the HIMSS AI panel she participated in on responsible AI, navigating ethical considerations and using the tech to decrease nurse burnout and improve patient outcomes.
AI is another tool in a provider's kit to help solve care challenges, but the difference is that it learns, says Dr. Rebecca Mishuris, CMIO and VP at Mass General Brigham. Thus, it is imperative to consider principals when deploying genAI.
Rachini Moosavi, University of North Carolina Health chief analytics officer, relays how UNC began developing AI in 2016, deploying the tech within clinical and financial operations, and how providers have responded to AI implementation.
Albert Marinez, chief analytics officer at Cleveland Clinic, relates how the health system uses AI to ease provider workflow, the responses it has received from physicians and lessons learned throughout the implementation process.
Arcadia's provider customers and life sciences users can leverage Atropos Health's datasets for value-based care and clinical decision-making.
Sara Shanti, partner at Sheppard Mullin, discusses the intersection of healthcare and technology, how to establish trust and transparency within AI, and questions she receives pertaining to virtual therapy, particularly in mental health.
The lawsuit, filed on behalf of purchasers of Veradigm's common stock, alleges the company and its executives overstated the business's historical revenues by at least $20 million.
Providers are responsible for navigating variable coverage schemes while caring for patients, says Jay Rughani, investment partner at Andreessen Horowitz. AI and LLMs advancements can help fix this trajectory and reduce administrative burnout.
The pharma giant will also pay $55 million to fund the point-of-care diagnostics platform until the acquisition closes, which is expected to occur by mid-2024.